BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace


BenevolentAI logo

United Kingdom based
$292 M

BenevolentAI combines advanced AI and machine learning with cutting edge science to decipher complex disease biology, generate novel insights and discover more effective medicines. Our unique computational R&D platform spans every step of the drug discovery process, powering an in-house pipeline of 25+ drug programmes from early discoverytowards clinical phases. With several successful collaborations with leading pharmaceutical organisations, we are also the only AI-drug discovery company with a clinically validated approach, having discovered a leading repurposed drug candidate for COVID-19. BenevolentAI is headquartered in London with a research facility in Cambridge (UK) and a further office in New York, with a team of over 300 world-leading scientists and technologists progressing its mission to reinvent drug discovery and advance life-changing drugs through to the clinic.


AI Companies (Drug Discovery)   Pharmaceutical and Drug Discovery  

Posts Mentioning This Company

Biopharma Insights
Video gallery
Biopharma Insights

R&D Platform


The Benevolent Platform

Read more


BenevolentAI Pipeline
Clinical  |  Visit website

The Benevolent Platform empowers our drug discoverers to create a growing pipeline of novel medicines for untreated or poorly treated diseases.




No services posted yet